timeeurope.com

TIME Europe Home
  Europe
  Middle East
  Africa
  World
  Digital Europe
  Business
  Travel & Arts
  Photo Essays
  TIME Trails
  Magazine
  Archive
  Fast Forward

Special Features
  Fast Forward
  Forecast 2001
  E-Europe
Search TIME Europe
 
Subscribe to TIME
Subscriber Services
About Us

TIME Daily
TIME Asia
TIME Canada
TIME Pacific
TIME Digital
Latest CNN News

FREE NEWSLETTER!
Sign up now for TIME's WorldWatch email newsletter.
[ preview ]

 


Other News
spacer gif
spacer gif
Check the New 2000
FORTUNE 500 Today!

FORTUNE.com

spacer gif
Sivy On Stocks,
By E-Mail

MONEY.com

spacer gif
The 'X-Men' Cometh
And EW's Got 'Em!

ENTERTAINMENT WEEKLY

spacer gif



TIME EUROPE
January 15, 2000, Vol. 157 No. 2


Going up in Smoke
Switzerland, land of luxury watches and bank secrecy, has a new growth industry: marijuana
By NICHOLAS LE QUESNE Zurich

Bernhard Mächler has shoulder-length brown hair and finely chiseled features. He's gunning a sporty blue Mazda along country roads north of Zurich toward Ossingen. Fast, with no seat belt. "We've got electronic alarm systems, entry codes and fields guarded by dog handlers 24 hours a day," he says. "Our problems aren't with organized crime, they're with 17-year-old kids." He breaks off to overtake a slow-moving cyclist, cutting back just in time to avoid an oncoming truck. "The only real trouble was at the shop in Baden," he continues. "Three guys walked in and put pistols to the assistants' heads." Mächler is talking business, and his business is selling marijuana.

For most Europeans, Switzerland is a conservative place of chocolates, bank secrecy and luxury watches. Now another product, cannabis, is on its way to becoming as quintessentially Swiss as the multifunction penknife. Mächler is a manager and founding member of the Enetbrugg cooperative, which employs 200 people and racked up revenues of $5.5 million in 1999 by growing the weed and selling it to the country's burgeoning network of legal hemp shops. The cooperative's revenues were lower last year.

In late September, police helicopters swooped down on its fields to seize 70,000 top-grade marijuana plants. Mächler spent 16 days in jail, along with the five other Enetbrugg founders, and puts the group's net loss from the episode at $1.7 million. Yet he is not one to bear a grudge. "I don't blame the police," he says. "They're just doing their job."

The bust — and Mächler's reaction to it — highlight the legal ambiguity of Switzerland's cannabis economy. Technically, growing or selling the plant is legal unless it's to be used as a narcotic. Proving that seized marijuana was intended for that purpose is a job for the police and the courts. "If you said you were selling it to treat epilepsy, the police would have to follow buyers home to see what they did with it," says Thomas Zeltner, head of the Federal Office of Public Health. "It's an interesting example of a sector of agriculture finding loopholes in the legislation and then taking advantage of them."

The marijuana business has mushroomed in recent years. Twenty hemp shops were trading across Switzerland in 1997. Today there are as many as 300. Official figures show 250 hectares of fields producing marijuana for some 600,000 occasional-to-regular consumers. The Swiss Hemp Coordination — a mouthpiece for the cannabis industry in its dealings with Swiss authorities — reckons that 30% of production is distributed through hemp shops, with sales for the sector as a whole running at $550 million a year.

"A lot of shops are making a lot of money because the margins are very high," says the Coordination's president François Reusser, who also runs the Zurich hemp shop Chanf. Behind him, a handful of youngsters are bagging up dried marijuana buds from huge paper sacks. A 9-g bag sells for around $28. "Some shops make a 50% markup on wholesale prices," says Reusser, who professes to keep his margins at 30%. "But we do have to write off losses from police seizures," he adds, "just as other shops write off losses from shoplifting."

The store has an airy, modern feel. Its shelves and other display spaces are crammed with a bewildering array of products: hemp cosmetics, hemp clothes, hemp washing powder and hemp paper. A refrigerator is stocked with hemp wine, hemp spirits and hemp beer. There are books to help you cook hemp and accessories to help you smoke it. But most customers make straight for the counter and its white plastic drawer of cellophane-wrapped marijuana. "Hemp shops are basically places that sell grass," says Reusser. "The rest has been a good way of camouflaging an illegal activity. I like all the other stuff, but it doesn't make a lot of money."

Reusser insists that his primary goal is not so much making money as changing the law. He may be about to get what he wants. The federal government announced plans this autumn to decriminalize personal possession and consumption of cannabis. In February it will unveil proposals to regulate shops and growers, a move that could involve Dutch-style tolerance, subject to a few conditions: sales restricted to certain outlets and forbidden to minors or foreigners. After parliamentary debate, a new law could take effect in 2002. "We certainly don't want to become a country which exports cannabis," says Zeltner, "and the Swiss government will not take the step of legalizing the substance." But well-dressed men are already rolling joints in Swiss train carriages without fellow passengers batting an eyelid. Heidi wouldn't recognize the place.

This edition's table of contents
TIME Europe home


More stories from TIME Europe and related links

E-mail us at mail@timeatlantic.com

Like what you're reading?
Click here to try 4 FREE ISSUES of TIME






More Stories

COVER STORY
Special Report: The Future of Medicine
With the mapping of the human genome the process by which new drugs are developed is being turned upside down. These drugs will also change our lives

Brave New Pharmacy
Using high-speed robots and the secrets of the human genome, scientists are changing forever the way they discover new medicine

The Hunt for Cures
Genetic information could lead to treatments for everything from AIDS to obesity

EUROPE
Prague Winter
When Jiri Hodac was named director of state television, Czech journalists saw a return to government meddling in the media

See Vous in Court
France is the latest nation to join the litigation game

Going up in Smoke
Switzerland, land of luxury watches and bank secrecy, has a new growth industry: marijuana

UNITED STATES
The True Blue Bush Cabinet
Its ethnic and gender balance is correct, but can a divided nation deal with the super-conservative bent?

BUSINESS
Transparency has its Price
Executives at many German companies are finding it hard to adjust to the more rigorous financial disclosure required by global investors

On Spreading the Word
When it comes to selling merchandise, word-of-mouth marketing may be a company's best weapon

Essay: Meat Matters
Critics of industrialized farming may be forgetting about world hunger, writes TIME's Rod Usher

THE ARTS
Rebel with a Cause
The real-life story of an anti-Mafia activist in Sicily makes for a handsome film with a political message

The Upmarketeer's Tale
Bernard Arnault built his house by selling at deluxe prices and in his book he's still giving nothing away

The Art of Noise
For Europe's freely improvised music, the only rule is no rule

DEPARTMENTS
Techwatch

World Watch

WHAT DO YOU THINK?
E-mail us at mail@timeatlantic.com

Copyright © 2001 Time Inc. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
E-mail us:  Letter to the Editor | Customer Service
Privacy Policy | Terms of Use | Press Releases